Local Institution - 0011

Ciudad Autónoma de Buenos Aires, Buenos Aires 1426

1 studies enrolling now · 3 studies all time

What they study most

Advanced Cancer, Breast Neoplasms, Renal Cell Carcinoma

Studies at this site

• A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) — Recruiting now
• A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer — Running, not enrolling
• An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers — Completed